Love Pharma Inc. (CNSX:LUV) entered into a definitive agreement to acquire Doc Hygiene Pharmaceuticals Inc. for $0.3 million on August 16, 2022. Pursuant to the Agreement, at closing of the Acquisition, the Company will assume approximately US$150,000 of liabilities of Doc Hygiene and will pay the purchase price through the issuance of a convertible promissory note representing an aggregate principal amount of US$150,000 (the “Promissory Note”). All amounts represented by the Promissory Note shall be payable on the five (5) year anniversary of the date of issuance of the note and will bear interest at a rate of ten percent (10%) per annum, payable quarterly in arrears. The principal amount of the Promissory Note shall be convertible into common shares in the capital of the Company (the “Common Shares”). the Acquisition is accretive and builds value for shareholders by combining Doc Hygiene's trusted line of personal sanitizer products with LOVE's growing line of science-backed nutraceutical and psychedelic products.

Love Pharma Inc. (CNSX:LUV) completed the acquisition of Doc Hygiene Pharmaceuticals Inc. on October 19, 2022.